Van Plew Daniel P's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Feb 16, 2024
- Accession no.
- 0001968202-24-000066
- Filed
- Feb 16, 2024
- Trade date
- Feb 14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions. Open-market sales total $9.83M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Plew Daniel PCIK 0001411984 | Officer (EVP & General Mgr, Industrial) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | Common Stock | SSaleDisposed | −439 | $937.94F1 | −$411,755.66 | 30,373 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −226 | $938.13F2 | −$212,017.38 | 30,147 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −750 | $939.60F3 | −$704,700 | 29,397 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −4,261 | $940.44F4 | −$4,007,214.84 | 25,136 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −275 | $941.41F5 | −$258,887.75 | 24,861 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −2,691 | $943.51F6 | −$2,538,985.41 | 22,170 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −620 | $944.30F7 | −$585,466 | 21,550 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −95 | $945.81F8 | −$89,851.95 | 21,455 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −240 | $947.81F9 | −$227,474.4 | 21,215 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −150 | $948.70F10 | −$142,305 | 21,065 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −112 | $949.07F11 | −$106,295.84 | 20,953 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −375 | $950.45F12 | −$356,418.75 | 20,578 | Direct | |
| Feb 14, 2024 | Common Stock | SSaleDisposed | −200 | $951.77F13 | −$190,354 | 20,378 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents volume-weighted average price of sales of 439 shares of Company stock on February 14, 2024 at prices ranging from $937.86 to $937.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents volume-weighted average price of sales of 226 shares of Company stock on February 14, 2024 at prices ranging from $938.00 to $938.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 750 shares of Company stock on February 14, 2024 at prices ranging from $939.39 to $939.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 4,261 shares of Company stock on February 14, 2024 at prices ranging from $940.06 to $940.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 275 shares of Company stock on February 14, 2024 at prices ranging from $941.09 to $941.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 2,691 shares of Company stock on February 14, 2024 at prices ranging from $943.23 to $943.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 620 shares of Company stock on February 14, 2024 at prices ranging from $944.29 to $944.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 95 shares of Company stock on February 14, 2024 at prices ranging from $945.66 to $945.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 240 shares of Company stock on February 14, 2024 at prices ranging from $947.77 to $947.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 150 shares of Company stock on February 14, 2024 at prices ranging from $948.13 to $948.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F11
Represents volume-weighted average price of sales of 112 shares of Company stock on February 14, 2024 at prices ranging from $949.02 to $949.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F12
Represents volume-weighted average price of sales of 375 shares of Company stock on February 14, 2024 at prices ranging from $950.37 to $950.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F13
Represents volume-weighted average price of sales of 200 shares of Company stock on February 14, 2024 at prices ranging from $951.61 to $951.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2024 at each separate price.
Referenced by the price of 1 transaction in Table I.